Article Information
- Received March 18, 2002
- Revision received May 30, 2002
- Accepted June 5, 2002
- First published August 15, 2002.
- Version of record published August 15, 2002.
Author Information
- Paolo Gubellini1,3,
- Barbara Picconi1,4,
- Monica Bari2,
- Natalia Battista2,
- Paolo Calabresi1,4,
- Diego Centonze1,4,
- Giorgio Bernardi1,4,
- Alessandro Finazzi-Agrò2, and
- Mauro Maccarrone2
- 1Dipartimentos di Neuroscienze and
- 2Medicina Sperimentale e Scienze Biochimiche, Università degli Studi di Roma “Tor Vergata”, 00133 Roma, Italy,
- 3Istituto di Neurobiologia e Medicina Molecolare, Consiglio Nazionale delle Ricerche, 00133 Roma, Italy, and
- 4Istituto di Ricovero e Cura a Carattere Scientifico Fondazione “Santa Lucia”, 00179 Roma, Italy
Author contributions
Disclosures
- Received March 18, 2002.
- Revision received May 30, 2002.
- Accepted June 5, 2002.
This work was supported by a Schizophrenia Finalized Project (Istituto di Ricovero e Cura a Carattere Scientifico “S. Lucia”) to P.C., and two Ministero dell'Università e della Ricerca Scientifica e Tecnologica, Consiglio Nazionale delle Ricerche Biotechnology Programs (L. 95/95) to G.B. and A.F.-A. We thank Dr. J.-L. Gaı̈arsa (Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Marseille, France) for his kind advice on spontaneous activity study, Prof. R. Pertwee (University of Aberdeen, UK) for his helpful discussion on anandamide binding, Dr. A. Cartoni for the analysis of endogenous cannabinoid levels, and M. Tolu for his technical assistance.
Correspondence should be addressed to Dr. Paolo Calabresi, Dipartimento di Neuroscienze, Università di Roma “Tor Vergata,” Via Montpellier 1, 00133 Roma, Italy, E-mail:paolo.calabresi{at}uniroma2.it or Dr. Mauro Maccarrone, Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università di Roma “Tor Vergata,” Via Montpellier 1, 00133 Roma, Italy, E-mail:maccarrone{at}med.uniroma2.it.
Online Impact